Glaxosmithkline | GSK - 流动负债

股票价格
49.61
每天变化
-1.29 -2.53%
每月一次
-1.76%
每年
31.80%
Q2 预测
49.84


金融业
股票价格
GBP
资产
GBP 82.34B
现金及等价物
GBP 3.3B
销售成本
GBP 3.47B
流动资产
GBP 23.59B
流动负债
GBP 28.82B
债务
GBP 17.75B
股息收益率
GBP 4.47
EBIT
GBP 2.3B
EBITDA
GBP 4.75B
员工
GBP 69.4K
EPS每股收益
GBP 0.62
股本和储备
GBP 22.06B
销售毛利
GBP 8.75B
债务利息支出
GBP 177.95M
利息收入
GBP 26M
贷款资金
GBP 19.82B
市值
GBP 102.83B
净收入
GBP 846.06M
营业费用
GBP 9.17B
营业利润
GBP 2.3B
普通股股本
GBP 4.08B
PE价格收益
11.66
税前利润
GBP 2.46B
销售收入
GBP 10.09B
销售和管理费用
GBP 3.56B
股票
GBP 6.12B
贸易债权人
GBP 20.72B
应收帐款人
GBP 10.45B


流动负债 更改 日
AbbVie USD 42.1B 1.19B 2026-03
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bausch Health Companies USD 4.53B 350M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Glaxosmithkline GBP 28.82B 144.79M 2025-12
J&J USD 57.72B 3.59B 2026-03
Merck USD 26.94B 1.38B 2026-03
Novartis USD 31.37B 4.1B 2026-03
Pacira USD 108.79M 11.8M 2026-03
Perrigo USD 997.6M 15.3M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
Phibro Animal Health USD 281.87M 500K 2026-03
Prestige Brands USD 120.92M 18.63M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Takeda JPY 2.43T 180.65B 2026-03
Teva Pharmaceutical Industries USD 13.53B 76M 2026-03
Zoetis USD 2.05B 182M 2026-03